Edition:
United States

Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

187.25USD
29 Mar 2017
Change (% chg)

-- (--)
Prev Close
$187.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
184
52-wk High
$195.20
52-wk Low
$157.68

Latest Key Developments (Source: Significant Developments)

Lonza Group raises 865 mln Sfr from bookbuilding, shares placed 173 Sfr per share
Wednesday, 1 Feb 2017 01:22am EST 

Lonza Group Ag says : successfully places 5.0 million new shares, raising gross proceeds of 865 million Sfr . the shares were placed at 173.00 Swiss francs per new share . new shares are expected to be listed and admitted to trading on the SIX Swiss Exchange on 3. February 2017 . Additionally, Lonza has entered into lock up undertakings ending on the later of (1) 180 days following the first day of trading of the new shares issued in the Placement and (2) if the additional equity issuance proceeds, as referenced in Lonza's announcement of the Capsugel acquisition on 15 December 2016, 90 days following the first day of trading of the shares issued in that equity issuance Further company coverage: [LONN.S] (Reporting By Zurich newsroom) ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;)).  Full Article

Bookrunner gives pricing guidance on Lonza Group offering
Tuesday, 31 Jan 2017 12:00pm EST 

Bookrunner: Lonza Group AG ABB: bookrunner says visibility on potential investor interest in excess of 70 pct the deal size, from a limited market sounding exercise . Lonza Group AG ABB: bookrunner says pricing guidance of CHF172 to market Further company coverage: [LONN.S] (Bengaluru Newsroom) ((+91 806 749 1136;)).  Full Article

Bookrunner says transaction covered in Lonza Group placing
Tuesday, 31 Jan 2017 11:42am EST 

Lonza Group AG : Lonza Group AG: bookrunner says transaction covered in accelerated bookbuild Further company coverage: [LONN.S] (Bengaluru Newsroom) ((+91 806 749 1136;)).  Full Article

Lonza launches accelerated bookbuilding
Tuesday, 31 Jan 2017 11:02am EST 

Lonza Group AG says : Following the announcement on 15 December 2016 regarding the contemplated acquisition of Capsugel, Lonza launches an accelerated bookbuilding by offering up to 5.0 million registered shares . As a result, Lonza's share capital will increase by a maximum of 9.4 percent of the share capital as currently registered in the commercial register . net proceeds from the capital increase are intended to be used to partially finance the acquisition of Capsugel . Transaction will be executed by way of a primary placement ("placement") of shares excluding subscription rights of existing shareholders . new shares are expected to be listed and admitted to trading on the SIX Swiss Exchange on 3 February 2017 Further company coverage: [LONN.S] (Reporting By Zurich newsroom) ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;)).  Full Article

Lonza to acquire Capsugel for $5.5 bln
Thursday, 15 Dec 2016 12:30am EST 

Lonza Group Ag : Lonza to acquire Capsugel to create leading integrated solutions provider to the global pharma and consumer healthcare industries . Says to acquire Capsugel for $5.5 billion . Says transaction is expected to be core EPS accretive in first full year post closing . Says expects to achieve CHF 30 million p.a. operating synergies and CHF 15 million tax synergies per annum by year three . Says intends to retain current dividend policy and maintain about 3x net debt/EBITDA leverage . Says deal includes refinancing of existing Capsugel debt of approximately $2 billion . Says has committed debt financing for full acquisition amount from BofA Merrill lynch and UBS and plans to raise equity . Says financial package foresees refinancing of Lonza's current CHF 700 million revolving credit facility .Says all-cash acquisition of Capsugel will be financed with a combination of debt and equity financing.  Full Article

Lonza to divest peptides business to PolyPeptide Group
Wednesday, 7 Dec 2016 01:10am EST 

Lonza Group Ag : Lonza to divest peptides business and operations in Braine-l'Alleud (Belgium) to PolyPeptide . Lonza and the PolyPeptide Group jointly announced today that PolyPeptide Laboratories Holding (PPL) has entered into a definitive agreement with Lonza Sales AG and Lonza AG . Financial terms of transaction are not disclosed . Will book a non-cash related write-off of chf 44 million in second half of 2016 and then book a non-cash currency translation impact at closing of transaction Further company coverage: [LONN.S] (Reporting by Brenna Hughes Neghaiwi) ((brenna.neghaiwi@thomsonreuters.com; +41 58 306 77 35;)).  Full Article

Lonza raises guidance for core EBIT growth in 2016
Wednesday, 20 Jul 2016 01:04am EDT 

Lonza Group AG : Raising its guidance for core ebit growth and now expects a double-digit improvement in core ebit for full year of 2016 .Strong cash flow generation is expected to further reduce net debt significantly by end of fiscal year 2016.  Full Article

Lonza Group: Rodolfo Savitzky to succeed Toralf Haag as CFO
Tuesday, 10 May 2016 01:15am EDT 

Lonza Group AG : Rodolfo Savitzky to succeed Toralf Haag as Lonza Group CFO .Change will be effective as of October 1, 2016, when Rodolfo Savitzky will also succeed Toralf Haag as a member of Lonza Executive Committee.  Full Article

Lonza Group comments on first half of FY 2016 earnings outlook
Tuesday, 26 Apr 2016 01:00am EDT 

Lonza Group AG:Double-Digit core EBIT growth expected for first half of FY 2016.  Full Article

Lonza Group gives FY 2016 guidance and comments on mid-term FY 2018 outlook, proposes dividend
Wednesday, 27 Jan 2016 01:00am EST 

Lonza Group AG:‍In 2016 Lonza is expected to grow sales in line with 2018 guidance and targets a core EBIT growth of above 5 pct​.Sees ‍core EBITDA approaching 1 billion Swiss francs in 2018​ ‍.Sees ‍sales growth of low to mid-single digits on average per year until 2018​​.Proposing a stable dividend of 2.50 Swiss francs per share for FY 2015.  Full Article

More From Around the Web

EU mergers and takeovers (March 30)

BRUSSELS, March 30 The following are mergers under review by the European Commission and a brief guide to the EU merger process: